Dasatinib synergises with irinotecan to suppress hepatocellular carcinoma via inhibiting the protein synthesis of PLK1
2017 · British Journal of Cancer · 35 citations
https://doi.org/10.1038/bjc.2017.55
J
Jinjin Shao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Jinjin Shao is an academic researcher.
ORCID: 0000-0002-1435-9212Papers by this author
worksDiosmetin protects against retinal injury via reduction of DNA damage and oxidative stress
2015 · Toxicology Reports · 21 citations
https://doi.org/10.1016/j.toxrep.2015.12.004
Chidamide improves gefitinib treatment outcomes in NSCLC by attenuating recruitment and immunosuppressive function of myeloid-derived suppressor cells
2024 · Biomedicine & Pharmacotherapy · 10 citations
https://doi.org/10.1016/j.biopha.2024.116306
HDAC1-3 inhibition triggers NEDD4-mediated CCR2 downregulation and attenuates immunosuppression in myeloid-derived suppressor cells
2025 · Cancer Immunology Immunotherapy · 4 citations
https://doi.org/10.1007/s00262-024-03931-y
Chat about Author
Papers
Chat
Click to start Chat